Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 9.39 is 21% above its 1-year average of 7.78, around the middle of its 1-year range (0.00–13.94).
As of the fiscal period ended Tuesday, June 30, 2026. 19.54% below its 12-month average of 11.67.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.39.
QUICK RATIO (ACID-TEST)
9.39
QUICK RATIO (ACID-TEST) AVG TTM
11.67
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-19.54%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.11
median of 688 covered companies
CURRENT VS SECTOR MEDIAN
+201.79%
vs the sector median at left
Attovia Therapeutics, Inc.
Market Cap
$780.99M
Quick Ratio (Acid-Test)
9.39
TTM Avg
11.67
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$770.72M
Quick Ratio (Acid-Test)
18.86
TTM Avg
23.23
3Y Avg
26.78
5Y Avg
32.61
Market Cap
$770.55M
Quick Ratio (Acid-Test)
1.52
TTM Avg
0.88
3Y Avg
1.36
5Y Avg
2.75
Market Cap
$787.65M
Quick Ratio (Acid-Test)
13.29
TTM Avg
5.16
3Y Avg
5.49
5Y Avg
4.89
Market Cap
$795.58M
Quick Ratio (Acid-Test)
0.98
TTM Avg
0.95
3Y Avg
0.97
5Y Avg
0.95
Market Cap
$790.35M
Quick Ratio (Acid-Test)
5.16
TTM Avg
4.89
3Y Avg
3.82
5Y Avg
4.31
Market Cap
$796.03M
Quick Ratio (Acid-Test)
3.86
TTM Avg
4.02
3Y Avg
3.56
5Y Avg
3.80
Market Cap
$752.87M
Quick Ratio (Acid-Test)
16.09
TTM Avg
8.04
3Y Avg
7.87
5Y Avg
9.13
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | $780.99M | 9.39 | 11.67 | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $770.72M | 18.86 | 23.23 | 26.78 | 32.61 |
| Mesa Laboratories, Inc. (MLAB)vs › | $770.55M | 1.52 | 0.88 | 1.36 | 2.75 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $787.65M | 13.29 | 5.16 | 5.49 | 4.89 |
| AdaptHealth Corp. (AHCO)vs › | $795.58M | 0.98 | 0.95 | 0.97 | 0.95 |
| Geron Corporation (GERN)vs › | $790.35M | 5.16 | 4.89 | 3.82 | 4.31 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $796.03M | 3.86 | 4.02 | 3.56 | 3.80 |
| Candel Therapeutics, Inc. (CADL)vs › | $752.87M | 16.09 | 8.04 | 7.87 | 9.13 |
| InMode Ltd. (INMD)vs › | $805.31M | 7.28 | 9.00 | 9.42 | 9.03 |
| Apnimed, Inc. (APMD)vs › | $807.61M | N/A | N/A | N/A | N/A |
Quick Ratio
9.39
Excludes inventory
Current Ratio
9.39
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 9.39 |
| 2026-03-31 | 13.94 |
| 2025-03-31 | 0.00 |
